The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development
- PMID: 35463205
- PMCID: PMC9030405
- DOI: 10.2147/JAA.S324080
The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development
Abstract
The respiratory epithelium constitutes the physical barrier between the human body and the environment, thus providing functional and immunological protection. It is often exposed to allergens, microbial substances, pathogens, pollutants, and environmental toxins, which lead to dysregulation of the epithelial barrier and result in the chronic inflammation seen in allergic diseases and asthma. This epithelial barrier dysfunction results from the disturbed tight junction formation, which are multi-protein subunits that promote cell-cell adhesion and barrier integrity. The increasing interest and evidence of the role of impaired epithelial barrier function in allergy and asthma highlight the need for innovative approaches that can provide new knowledge in this area. Here, we review and discuss the current role and mechanism of epithelial barrier dysfunction in developing allergic diseases and the effect of current allergy therapies on epithelial barrier restoration.
Keywords: allergy; asthma; bronchial epithelial cells; inflammation; tight junction.
© 2022 Noureddine et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures



Similar articles
-
Epithelial barriers in allergy and asthma.J Allergy Clin Immunol. 2020 Jun;145(6):1499-1509. doi: 10.1016/j.jaci.2020.04.010. J Allergy Clin Immunol. 2020. PMID: 32507228 Free PMC article. Review.
-
Epithelial barrier dysfunction in ocular allergy.Allergy. 2022 May;77(5):1360-1372. doi: 10.1111/all.15174. Epub 2021 Nov 28. Allergy. 2022. PMID: 34757631 Free PMC article. Review.
-
Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation.J Allergy Clin Immunol. 2014 Sep;134(3):509-20. doi: 10.1016/j.jaci.2014.05.049. Epub 2014 Jul 29. J Allergy Clin Immunol. 2014. PMID: 25085341 Free PMC article. Review.
-
Involvement and therapeutic implications of airway epithelial barrier dysfunction in type 2 inflammation of asthma.Chin Med J (Engl). 2022 Feb 16;135(5):519-531. doi: 10.1097/CM9.0000000000001983. Chin Med J (Engl). 2022. PMID: 35170505 Free PMC article. Review.
-
Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis.J Allergy Clin Immunol. 2019 Nov;144(5):1242-1253.e7. doi: 10.1016/j.jaci.2019.04.027. Epub 2019 May 11. J Allergy Clin Immunol. 2019. PMID: 31082457
Cited by
-
Quercetin improves and protects Calu-3 airway epithelial barrier function.Front Cell Dev Biol. 2023 Nov 23;11:1271201. doi: 10.3389/fcell.2023.1271201. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38078004 Free PMC article.
-
Innate Immunity, Epithelial Plasticity, and Remodeling in Asthma.Adv Exp Med Biol. 2023;1426:265-285. doi: 10.1007/978-3-031-32259-4_13. Adv Exp Med Biol. 2023. PMID: 37464126
-
The barrier-protective effect of β-eudesmol against type 2-inflammatory cytokine-induced tight junction disassembly in airway epithelial cells.PLoS One. 2024 Apr 30;19(4):e0302851. doi: 10.1371/journal.pone.0302851. eCollection 2024. PLoS One. 2024. PMID: 38687777 Free PMC article.
-
Exosomes derived from M2 macrophages regulate airway inflammation by modulating epithelial cell proliferation and apoptosis.J Inflamm (Lond). 2025 May 19;22(1):19. doi: 10.1186/s12950-025-00444-y. J Inflamm (Lond). 2025. PMID: 40390011 Free PMC article.
-
Claudin-1 Mediated Tight Junction Dysfunction as a Contributor to Atopic March.Front Immunol. 2022 Jun 29;13:927465. doi: 10.3389/fimmu.2022.927465. eCollection 2022. Front Immunol. 2022. PMID: 35844593 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources